Viewing nowCombinationAvesmet Tablet 50/1000 mg (Vildagliptin, Metformin Hydrochloride)
Metformin Hydrochloride 300mg · Vildagliptin 50mg
Tablet · Prescription medication · Combination
Ankook Pharmaceutical Co., Ltd.

MFDS item code 202401283 · Approved 2024.05.24 · Insurance code 650206100
Improvement of blood glucose control in type 2 diabetes mellitus
This medication helps patients with type 2 diabetes to more effectively control their blood sugar levels. By combining Vildagliptin and Metformin, it complements dietary therapy and exercise, aiding in blood sugar management. Therefore, this medication is used to improve blood sugar control.
For the treatment of patients with type 2 diabetes, the dose of this medicine should be individualized based on efficacy and tolerability, within the limits of 100mg of vildagliptin and 2000mg of metformin. Doses of vildagliptin greater than 100mg per day are not recommended. This medicine is generally administered with food or immediately after a meal to reduce gastrointestinal adverse reactions caused by metformin. 1. Patients with no previous antidiabetic drug treatment whose blood glucose is inadequately controlled with monotherapy: The initial dose is 1 tablet of this medicine 50/500mg once daily; the dose may be increased gradually up to 1 tablet of 50/1000mg twice daily. 2. Patients whose blood glucose is not adequately controlled with metformin monotherapy: The initial dose of this medicine is 100mg of vildagliptin per day plus the patient's existing dose of metformin. The initial dose of this medicine is determined according to the patient's current treatment regimen; take 1 tablet of this medicine 50mg/850mg or 50mg/1000mg twice daily, in the morning and evening. 3. Patients switching from combination therapy with vildagliptin and metformin: Patients switching from combination therapy with vildagliptin and metformin to this medicine may start at their existing doses of vildagliptin and metformin. 4. Use in combination with a sulfonylurea or insulin: Administer vildagliptin 50mg twice daily (total daily dose 100mg) and administer metformin at a dose similar to the existing dose. - When this medicine is used in combination with a sulfonylurea, a reduction in the sulfonylurea dose may be necessary to reduce the risk of hypoglycemia. No studies have been conducted to evaluate the safety and efficacy of switching from another oral antihyperglycemic agent to this medicine. Any change in treatment for type 2 diabetes may cause changes in blood glucose control; therefore, caution should be exercised and appropriate monitoring should be performed. If you miss a dose of this medicine, take it with your next meal unless it is time to take the missed dose; do not take a double dose at one time to make up for the missed dose. Patients with hepatic impairment This medicine is not recommended for patients with clinical or laboratory evidence of hepatic impairment, including patients whose ALT or AST levels exceed 2.5 times the upper limit of normal, before starting treatment.
This medication contains Metformin and Vildagliptin and is used for the treatment of diabetes. The most important caution when taking this medication is the risk of a serious side effect known as lactic acidosis. Lactic acidosis is a dangerous condition caused by the excessive buildup of lactic acid in the body, and immediate treatment is necessary if symptoms appear. Patients with moderate to severe renal impairment should not take this medication. Impaired kidney function can lead to drug accumulation in the body and increase the risk of side effects. Patients with heart failure, cardiovascular issues, acute infections, severe trauma, or liver dysfunction should also avoid this medication. In particular, patients scheduled for surgery should stop this medication 48 hours prior to the surgery and restart only after renal function has been confirmed as normal post-surgery. Pregnant or breastfeeding women should not take this medication, nor should patients with genetic conditions such as lactose intolerance. During treatment with this medication, patients should be cautious if they have irregular meal patterns, engage in intense exercise, or take other medications, as the risk of hypoglycemia or lactic acidosis may increase. Common side effects of this medication include dizziness, headache, nausea, and hypoglycemia; rare side effects such as liver dysfunction and skin rash have also been reported. If symptoms of acute pancreatitis occur, stop taking the medication immediately and seek medical attention. Alcohol consumption may increase the risk of lactic acidosis when taken with this medication, so it is advisable to avoid drinking. Regular monitoring of kidney and liver function is required while taking this medication, and periodic blood tests are recommended as vitamin B12 deficiency may occur. In case of overdose, immediate treatment is necessary, and blood dialysis may be helpful. Special caution is needed for children, adolescents, and the elderly, and dosage adjustment is necessary for the elderly due to decreased kidney function. Finally, be cautious during activities such as driving or operating machinery if symptoms like dizziness appear while taking this medication.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. It is best to maintain a storage temperature between 1 and 30 degrees Celsius. Proper storage will help preserve the medication's effectiveness and prevent degradation.
Dark yellow oval film-coated tablet
30 tablets/bottle, 60 tablets/box [10 tablets/PTP X 6]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationMetformin Hydrochloride 300mg · Vildagliptin 50mg
Tablet · Prescription medication · Combination
Ankook Pharmaceutical Co., Ltd.
CombinationVildagliptin 50mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationVildagliptin 50mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationVildagliptin 50mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationVildagliptin 50mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Korea United Pharm, Co., Ltd.
CombinationVildagliptin 50mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Ahn-Guk Pharmaceutical Co., Ltd.
CombinationVildagliptin 50mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Samjin Pharmaceutical Co., Ltd.
CombinationVildagliptin 50mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
AhnGuk NewPharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.